• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用β3选择性肾上腺素能受体拮抗剂SR 59230A对人结肠中非典型β3肾上腺素能受体的功能证据

Functional evidence of atypical beta 3-adrenoceptors in the human colon using the beta 3-selective adrenoceptor antagonist, SR 59230A.

作者信息

De Ponti F, Gibelli G, Croci T, Arcidiaco M, Crema F, Manara L

机构信息

Department of Internal Medicine and Therapeutics, University of Pavia, Italy.

出版信息

Br J Pharmacol. 1996 Apr;117(7):1374-6. doi: 10.1111/j.1476-5381.1996.tb15294.x.

DOI:10.1111/j.1476-5381.1996.tb15294.x
PMID:8730727
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1909449/
Abstract

The role of beta 3-adrenoceptors in human colonic circular smooth muscle was assessed in vitro by use of the beta 3-selective antagonist SR 59230A. Isoprenaline, in the presence of the selective beta-adrenoceptor antagonists CGP 20712A (beta 1) and ICI 118551 (beta 2), both at 0.1 microM, concentration-dependently relaxed the preparation (pEC50 = 5.22). This effect was potently and competitively antagonized by SR 59230A with a pA2 of 8.31, while its R,R enantiomer SR 59483A gave an apparent pKB of 6.21. Relaxation was likewise produced by CGP 12177A (pEC50 = 6.05), but not by BRL 37344. Although only one of these beta 3-selective agonists was effective, the remarkably high potency of SR 59230A as a stereospecific antagonist of non-beta 1 non-beta 2 relaxation of human colonic muscle by isoprenaline provides strong functional evidence of beta 3-adrenoceptors in that tissue.

摘要

利用β3选择性拮抗剂SR 59230A在体外评估了β3肾上腺素能受体在人结肠环行平滑肌中的作用。在选择性β肾上腺素能受体拮抗剂CGP 20712A(β1)和ICI 118551(β2)均为0.1微摩尔的情况下,异丙肾上腺素使标本呈浓度依赖性舒张(pEC50 = 5.22)。SR 59230A对该效应有强效竞争性拮抗作用,pA2为8.31,而其R,R对映体SR 59483A的表观pKB为6.21。CGP 12177A同样可产生舒张作用(pEC50 = 6.05),但BRL 37344则不能。尽管这些β3选择性激动剂中只有一种有效,但SR 59230A作为异丙肾上腺素对人结肠肌肉非β1非β2舒张的立体特异性拮抗剂具有极高的效力,这为该组织中存在β3肾上腺素能受体提供了有力的功能证据。

相似文献

1
Functional evidence of atypical beta 3-adrenoceptors in the human colon using the beta 3-selective adrenoceptor antagonist, SR 59230A.使用β3选择性肾上腺素能受体拮抗剂SR 59230A对人结肠中非典型β3肾上腺素能受体的功能证据
Br J Pharmacol. 1996 Apr;117(7):1374-6. doi: 10.1111/j.1476-5381.1996.tb15294.x.
2
Differences between the third cardiac beta-adrenoceptor and the colonic beta 3-adrenoceptor in the rat.大鼠心脏第三种β-肾上腺素能受体与结肠β3-肾上腺素能受体之间的差异
Br J Pharmacol. 1996 Aug;118(8):2085-98. doi: 10.1111/j.1476-5381.1996.tb15648.x.
3
Functional evidence for the presence of beta 3-adrenoceptors in the guinea pig common bile duct and colon.豚鼠胆总管和结肠中存在β3 - 肾上腺素能受体的功能证据。
Pharmacology. 1995 Nov;51(5):288-97. doi: 10.1159/000139338.
4
Beta 1-, beta 2- and atypical beta-adrenoceptor-mediated relaxation in rat isolated aorta.β1、β2和非典型β-肾上腺素能受体介导的大鼠离体主动脉舒张
Br J Pharmacol. 2000 Feb;129(4):637-44. doi: 10.1038/sj.bjp.0703091.
5
Characterisation of the atypical beta-adrenoceptor in rabbit isolated jejunum using BRL 37344, cyanopindolol and SR 59230A.使用BRL 37344、氰胍心安和SR 59230A对兔离体空肠中的非典型β-肾上腺素能受体进行表征。
J Auton Pharmacol. 1999 Apr;19(2):91-5. doi: 10.1046/j.1365-2680.1999.00121.x.
6
Functional assessment of beta adrenoceptor subtypes in human colonic circular and longitudinal (taenia coli) smooth muscle.人结肠环形和纵行(结肠带)平滑肌中β肾上腺素能受体亚型的功能评估
Gut. 2000 Sep;47(3):337-42. doi: 10.1136/gut.47.3.337.
7
Atypical beta-adrenoceptors mediating relaxation in the human colon: functional evidence for beta3-rather than beta4-adrenoceptors.介导人类结肠舒张的非典型β-肾上腺素能受体:β3而非β4肾上腺素能受体的功能证据
Pharmacol Res. 1999 May;39(5):345-8. doi: 10.1006/phrs.1998.0440.
8
Influence of adrenodemedullation on beta 2- and beta 3-adrenoceptors mediating relaxation of oesophageal smooth muscle of spontaneously hypertensive rats.肾上腺髓质切除术对介导自发性高血压大鼠食管平滑肌舒张的β2 -和β3 -肾上腺素能受体的影响。
Br J Pharmacol. 1996 Dec;119(7):1355-60. doi: 10.1111/j.1476-5381.1996.tb16046.x.
9
Evidence against beta 3-adrenoceptors or low affinity state of beta 1-adrenoceptors mediating relaxation in rat isolated aorta.反对β3-肾上腺素能受体或β1-肾上腺素能受体低亲和力状态介导大鼠离体主动脉舒张的证据。
Br J Pharmacol. 2003 Jan;138(1):99-106. doi: 10.1038/sj.bjp.0705017.
10
Beta-adrenoceptor subtypes and the opening of plasmalemmal K(+)-channels in trachealis muscle: electrophysiological and mechanical studies in guinea-pig tissue.β-肾上腺素能受体亚型与气管平滑肌中质膜钾通道的开放:豚鼠组织的电生理和力学研究
Br J Pharmacol. 1993 Aug;109(4):1140-8. doi: 10.1111/j.1476-5381.1993.tb13741.x.

引用本文的文献

1
Efficacy and safety of vibegron for the treatment of irritable bowel syndrome in women: Results of a randomized, double-blind, placebo-controlled phase 2 trial.维格列汀治疗女性肠易激综合征的疗效和安全性:一项随机、双盲、安慰剂对照的 2 期临床试验结果。
Neurogastroenterol Motil. 2022 Dec;34(12):e14448. doi: 10.1111/nmo.14448. Epub 2022 Aug 16.
2
Modulatory effect of intestinal polyamines and trace amines on the spontaneous phasic contractions of the isolated ileum and colon rings of mice.肠道多胺和痕量胺对小鼠离体回肠和结肠环自发性相性收缩的调节作用。
Food Nutr Res. 2017 May 26;61(1):1321948. doi: 10.1080/16546628.2017.1321948. eCollection 2017.
3
2D-QSAR and 3D-QSAR/CoMSIA Studies on a Series of (R)-2-((2-(1H-Indol-2-yl)ethyl)amino)-1-Phenylethan-1-ol with Human β₃-Adrenergic Activity.一系列具有人β₃-肾上腺素能活性的(R)-2-((2-(1H-吲哚-2-基)乙基)氨基)-1-苯基乙醇的二维定量构效关系和三维定量构效关系/比较分子相似性指数分析研究
Molecules. 2017 Mar 5;22(3):404. doi: 10.3390/molecules22030404.
4
The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.《2013/14药理学简明指南:G蛋白偶联受体》
Br J Pharmacol. 2013 Dec;170(8):1459-581. doi: 10.1111/bph.12445.
5
Portal hypertension and liver cirrhosis in rats: effect of the β3-adrenoceptor agonist SR58611A.大鼠门静脉高压和肝硬化:β3 肾上腺素能受体激动剂 SR58611A 的作用。
Br J Pharmacol. 2012 Nov;167(5):1137-47. doi: 10.1111/j.1476-5381.2012.02074.x.
6
The rush to adrenaline: drugs in sport acting on the beta-adrenergic system.对肾上腺素的追捧:体育赛事中作用于β-肾上腺素能系统的药物。
Br J Pharmacol. 2008 Jun;154(3):584-97. doi: 10.1038/bjp.2008.164.
7
Functional, biochemical and molecular biological evidence for a possible beta(3)-adrenoceptor in human near-term myometrium.人类足月子宫肌层中可能存在β(3) -肾上腺素能受体的功能、生化及分子生物学证据。
Br J Pharmacol. 2000 Aug;130(8):1960-6. doi: 10.1038/sj.bjp.0703491.
8
Functional assessment of beta adrenoceptor subtypes in human colonic circular and longitudinal (taenia coli) smooth muscle.人结肠环形和纵行(结肠带)平滑肌中β肾上腺素能受体亚型的功能评估
Gut. 2000 Sep;47(3):337-42. doi: 10.1136/gut.47.3.337.
9
Pharmacological characterization of beta-adrenoceptors mediating relaxation of the rat urinary bladder in vitro.介导大鼠离体膀胱舒张的β-肾上腺素能受体的药理学特性
Br J Pharmacol. 1999 Aug;127(7):1744-50. doi: 10.1038/sj.bjp.0702709.
10
Functional and molecular biological evidence for a possible beta3-adrenoceptor in the human detrusor muscle.人类逼尿肌中可能存在β3肾上腺素能受体的功能和分子生物学证据。
Br J Pharmacol. 1999 Feb;126(3):819-25. doi: 10.1038/sj.bjp.0702358.

本文引用的文献

1
Beta 3-adrenoceptors and intestinal motility.
Fundam Clin Pharmacol. 1995;9(4):332-42. doi: 10.1111/j.1472-8206.1995.tb00507.x.
2
Lack of beta 3-adrenergic receptor mRNA expression in adipose and other metabolic tissues in the adult human.成年人体内脂肪组织及其他代谢组织中β3 - 肾上腺素能受体信使核糖核酸表达缺失。
Mol Pharmacol. 1993 Mar;43(3):343-8.
3
Tissue distribution of beta 3-adrenergic receptor mRNA in man.人β3 - 肾上腺素能受体mRNA的组织分布
J Clin Invest. 1993 Jan;91(1):344-9. doi: 10.1172/JCI116191.
4
Characterization of the human beta 3-adrenergic receptor gene.人类β3-肾上腺素能受体基因的特征分析
Mol Pharmacol. 1993 Aug;44(2):264-70.
5
Mediation of most atypical effects by species homologues of the beta 3-adrenoceptor.β3肾上腺素能受体的物种同源物对大多数非典型效应的介导作用。
Br J Pharmacol. 1994 Jul;112(3):911-9. doi: 10.1111/j.1476-5381.1994.tb13167.x.
6
Adrenergic lipolysis in guinea pig is not a beta 3-adrenergic response: comparison with human adipocytes.
Am J Physiol. 1994 Mar;266(3 Pt 2):R905-13. doi: 10.1152/ajpregu.1994.266.3.R905.
7
Functional properties of the rat and human beta 3-adrenergic receptors: differential agonist activation of recombinant receptors in Chinese hamster ovary cells.大鼠和人类β3 - 肾上腺素能受体的功能特性:中国仓鼠卵巢细胞中重组受体的不同激动剂激活作用
Mol Pharmacol. 1992 Oct;42(4):634-7.